Back to News
Market Impact: 0.2
Biotech Stocks At 52-Week Highs - OABI +13%, FRNM, EXEL, FTH, LFST
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
Biotech stocks hit new 52-week highs on Sept. 2, 2026, as investors responded to new regulatory milestones and/or positive financial updates, signaling incremental momentum for the group despite a lack of specific deal or earnings figures in the report.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Nissan eyes increasing U.S. production as new Rogue hybrid launches
- Volkswagen woes deepen as blue-chip index exit follows latest profit warning
- SoftBank Seeking Over $11 Billion in Junk Bond Deal for OpenAI Investment
- Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs
- Smart ring maker Oura, shareholders look to raise up to $2.2 billion in US IPO
- Alkermes stock jumps on positive ADHD drug trial results